Gene · 406949
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis. | J Exp Clin Cancer Res | 2021 | 34271943 | PubTator, text mining | PubMed |
| Human microRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2. | Nucleosides Nucleotides Nucleic Acids | 2021 | 34263708 | PubTator, text mining | PubMed |
| Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer. | Sci Rep | 2021 | 34262080 | PubTator, text mining | PubMed |
| Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine. | Chem Sci | 2021 | 34257858 | PubTator, text mining | PubMed |
| MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study. | Biomark Res | 2021 | 34256855 | PubTator, text mining | PubMed |
| Corrigendum to "LncRNA miR503HG inhibits epithelial-mesenchymal transition andangiogenesis in hepatocellular carcinoma by enhancing PDCD4 viaregulation of miR-15b" [Dig Liver Dis 53 (2021) 107-116]. | Dig Liver Dis | 2021 | 34253481 | PubTator, text mining | PubMed |
| SCMFMDA: Predicting microRNA-disease associations based on similarity constrained matrix factorization. | PLoS Comput Biol | 2021 | 34252084 | PubTator, text mining | PubMed |
| Circ_001209 aggravates diabetic retinal vascular dysfunction through regulating miR-15b-5p/COL12A1. | J Transl Med | 2021 | 34233716 | PubTator, text mining | PubMed |
| Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling. | Aging (Albany NY) | 2021 | 34233294 | PubTator, text mining | PubMed |
| The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer. | Cancer Res | 2021 | 34224372 | PubTator, text mining | PubMed |
| A modified protocol for successful miRNA profiling in human precision-cut lung slices (PCLS). | BMC Res Notes | 2021 | 34215333 | PubTator, text mining | PubMed |
| The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis. | Mol Cytogenet | 2021 | 34215297 | PubTator, text mining | PubMed |
| Interplay between Hypoxia and Extracellular Vesicles in Cancer and Inflammation. | Biology (Basel) | 2021 | 34209290 | PubTator, text mining | PubMed |
| Emerging Role of MicroRNA-200 Family in Dentistry. | Noncoding RNA | 2021 | 34208375 | PubTator, text mining | PubMed |
| MERTK-Mediated LC3-Associated Phagocytosis (LAP) of Apoptotic Substrates in Blood-Separated Tissues: Retina, Testis, Ovarian Follicles. | Cells | 2021 | 34207717 | PubTator, text mining | PubMed |
| Osteoblast Differentiation and Signaling: Established Concepts and Emerging Topics. | Int J Mol Sci | 2021 | 34206294 | PubTator, text mining | PubMed |
| Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases. | Life (Basel) | 2021 | 34206241 | PubTator, text mining | PubMed |
| EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. | Cancers (Basel) | 2021 | 34206026 | PubTator, text mining | PubMed |
| Extracellular Vesicles as a Novel Liquid Biopsy-Based Diagnosis for the Central Nervous System, Head and Neck, Lung, and Gastrointestinal Cancers: Current and Future Perspectives. | Cancers (Basel) | 2021 | 34205183 | PubTator, text mining | PubMed |
| Effects of Dietary n-3 and n-6 Polyunsaturated Fatty Acids in Inflammation and Cancerogenesis. | Int J Mol Sci | 2021 | 34203461 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406949/papers?page=61